Submit Deal

Robert Flamm

Senior Vice President at Burns McClellan

PR Consultant

Deal Bio

Total Deals7

Valued Deals5

Total Value£295M

Avg. Deal Size£59M

Market Context

Expertise (7)

Key Relationships

Sort

United States

Pharmaceuticals

PrivateMergerMajorityAcquisitionDomestic

target

Yumanity Therapeutics

bidder

Proteostasis Therapeutics

value n/a

32 dealmakers

United States

Pharmaceuticals

PrivateDomesticMajorityAcquisition

target

Arixa Pharmaceuticals

bidder

Pfizer

value n/a

4 dealmakers

United States

Pharmaceuticals

AcquisitionMinorityPrivatePrivate EquityDomestic

target

Excision Biotherapeutics

bidder

Anzu Partners

£43m

22 dealmakers

United States

Biotechnology

Private EquityDomesticPrivateVenture CapitalMinorityAcquisition

target

Antios Therapeutics

bidder

Amzak Capital Management

£69m

22 dealmakers

United States

Biotechnology

MinorityPrivate EquityPrivateCross BorderVenture CapitalAcquisition

target

Cincor Pharma

bidder

Bvf Partners

£104m

19 dealmakers

United States

Pharmaceuticals

Cross BorderAcquisitionMajorityPrivate

target

Yumanity Therapeutics (product Candidates)

bidder

Johnson & Johnson

£21m

11 dealmakers

United States

Biotechnology

PrivateAcquisitionDomesticMajority

target

KINETA

bidder

Yumanity Therapeutics

£55m

29 dealmakers

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.